StocktoriaMetaVia Inc. MTVA
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
1/9
Piotroski F — financial health
-47.85
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$13.7M | -$28.8M | -$15.9M | -$19.6M | -$15.3M |
| Net income | -$13.0M | -$27.6M | -$12.5M | -$14.0M | -$15.3M |
| Operating cash flow | -$15.7M | -$24.7M | -$10.8M | -$11.7M | -$15.1M |
| Free cash flow | -$15.7M | -$24.7M | -$10.8M | — | -$15.1M |
| Total assets | $11.1M | $16.3M | $22.8M | $33.5M | $16.8M |
| Total liabilities | $5.8M | $8.3M | $6.1M | $11.8M | $2.2M |
| Shareholders' equity | $5.3M | $7.9M | $16.7M | $21.8M | $14.6M |
| Ratios | |||||
| Return on assets | -116.6% | -169.7% | -54.7% | -41.7% | -91.0% |
| Return on equity | -243.3% | -347.9% | -74.7% | -64.2% | -104.7% |
| Current ratio | 1.93 | 1.94 | 3.78 | 2.85 | 7.69 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -47.85 (distress)
- Working capital / assets 0.47
- Retained earnings / assets -13.38
- EBIT / assets -1.232
- Equity / liabilities 0.921
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001638287 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.